Vitamin D insufficiency increases risk of illness
The COVID-19 pandemic has swept the globe, killing more than 4.5 million people as of this writing. The symptoms of a SARS-CoV-2 infection range from mild (similar to a common cold) to more severe manifestations such as bronchitis, pneumonia, acute respiratory distress syndrome, organ failure, and even death in those who are most susceptible.
The severity of COVID-19 infection is influenced by age, ethnicity, and “comorbidities” such as obesity, diabetes, hypertension (high blood pressure), and asthma., People who are young and in good health are more likely to have mild symptoms.
Many of the groups at risk for COVID-19 are also at risk for vitamin D deficiency, including the elderly, overweight, chronically ill, and certain ethnic groups. In fact, vitamin D deficiency appears to be an important comorbidity in its own right, and one that is easily modifiable through supplementation.,,,,,, However, many people are unaware of the importance of vitamin D in COVID-19 risks and outcomes.
The evidence suggests that vitamin D may be one of the most important nutritional contributors to COVID-19 risks.
In 2020 we highlighted the importance of vitamin D in posts titled Vitamin D in the News and Study Identifies Widespread Inadequacies of Immune Health Nutrients. Since 2020, more than 800 peer-reviewed articles have been published on the subject. The evidence suggests that vitamin D may be one of the most important nutritional contributors to COVID-19 risks.
Sun exposure influences COVID-19 risks and outcomes
Many variables affect sun exposure and vitamin D levels in the body: the latitude at which one resides, season (winter vs. summer), time of day, cloud cover, air pollution (which filters out UVB), skin melanin content (which absorbs UVB), age, and sunscreen use (which blocks UVB).,,,
In a study published in October 2021, scientists performed a comprehensive meta-analysis of all related published literature based on the association of vitamin D and COVID-19, which showed that a low vitamin D level is a critical risk factor for SARS-CoV-2 infection.
Additionally, there was a correlation between daily weather patterns and COVID-19 cases in 26 European countries. Low temperature, low UV index, and low cloud-free vitamin D UV dose (UVDVF) levels were correlated with COVID-19 prevalence. In other words, as the clouds rolled in, the cases began to rise.
These findings suggest that maintaining adequate vitamin D levels in the body, either through UV exposure or supplementation, may help reduce the risks of COVID-19. Most clinicians recommend supplementation, however, since excessive sun exposure increases the risk of skin cancer.
The significance of vitamin D deficiency for COVID-19
Vitamin D status is assessed by measuring circulating levels of its metabolite, 25-hydroxy-vitamin D (25(OH)D). A study of over 190,000 patients from all 50 states compared SARS-CoV-2 test results with matching 25(OH)D results from the preceding 12 months. There was a clear correlation between 25(OH)D levels and positive test results, as shown below. People with positive test results are very likely to have COVID-19.
Vitamin D (as 25(OH)D)
COVID-positive test results (% of those tested)
The group classified as vitamin D deficient (<20 ng/ml) were 50% more likely to test positive than those with “adequate” vitamin D levels (30-34 ng/ml). The correlation persisted across latitudes, races/ethnicities, sexes, and age ranges. Moreover, higher vitamin D levels (>55 ng/ml) were associated with an even lower risk than the supposedly “adequate” group.
The vitamin D-deficient group had a 21% mortality rate, compared to 3.1% mortality in the group with adequate vitamin D levels – a difference of nearly sevenfold.
Vitamin D deficiency is also associated with a more severe disease course. One study of COVID-19 patients evaluated 25(OH)D levels in those who were asymptomatic and in those who were severely ill with COVID-19. Nearly all of the severely ill group (97%) were vitamin D deficient, compared with 33% of the individuals who were asymptomatic. The vitamin D-deficient group also had a 21% mortality rate, compared to 3.1% mortality in the group with adequate vitamin D levels – a difference of nearly sevenfold.
More than a dozen meta-analyses have examined the association between vitamin D deficiency and COVID-19 risks by collating the results from studies around the world. The majority of the reviews have concluded that vitamin D deficiency increases the risk of a severe outcome.,,,,,,,,,,
Vitamin D supplementation reduces COVID-19 risks
Patients who took vitamin D supplements were 64% less likely to require the intensive care unit as compared to patients who did not take supplements.
In addition to observational studies, direct studies of vitamin D supplementation have begun. They indicate that vitamin D supplementation is associated with less severe COVID-19 infection and better outcomes.,,
A meta-analysis of studies involving 532 hospitalized patients with COVID-19 (189 taking vitamin D supplements, and 343 receiving usual care/placebo) showed that COVID-positive patients who took vitamin D supplements were 64% less likely to require the intensive care unit (ICU) as compared to patients who did not take supplements.
In a population study of more than 85,000 individuals, the mortality risk was assessed in subjects taking supplements who had adequate vitamin D levels (serum 25(OH)D > 30 ng/ml) as compared to vitamin D-deficient subjects who did not take the supplement (serum 25(OH)D < 20 ng/ml). The risk of COVID-19 mortality was 50% less in patients with adequate vitamin D supplementation compared with those who were deficient.
A review published in October 2021 notes: “There is a great deal of evidence that hypovitaminosis D (low vitamin D) is an independent and easily modifiable risk factor for severe forms of COVID-19 and death. Vitamin D supplementation is a simple, safe and inexpensive measure, which is effective in correcting hypovitaminosis D, which is present in more than 80% of adults with COVID-19.”
Why is vitamin D still controversial?
Despite the evidence, this topic remains controversial for multiple reasons:
- Some studies were poorly designed and did not show a correlation between vitamin D and infections.
- Low vitamin D may be a consequence of COVID-19 infection as well as a predisposing factor.,
- Larger clinical trials are needed to confirm the population studies and to determine optimal vitamin D levels.
In addition to the scientific issues, controversy arises from the concern that consumers may ignore other public health recommendations if they think that vitamin D supplementation alone could reduce the risk of infections.
Regarding this point, Dr. Helena Gibson-Moore of the British Nutrition Foundation says: “Despite some media headlines, it is important that vitamin D (or any other nutrient, food or supplement) is never positioned as a ‘magic bullet’ against COVID‐19… Even if robust evidence emerges for vitamin D (or another nutrient), it should be considered in the context of the other established approaches to combat the disease, such as vaccines, social distancing, wearing of masks, keeping windows open and hygiene measures.”37
While keeping these precautions in mind, many scientists think that vitamin D deserves greater emphasis now. A position statement from the Spanish Society of Geriatrics and Gerontology argues that “…in an ideal world, health decisions must be made based on overwhelming evidence, but a time of crisis such as the current one may require a slightly different set of rules.”
Vitamin D: a prudent approach
Evidence to date suggests the possibility that the COVID-19 pandemic sustains itself in large part through infection of those with low vitamin D.
To raise awareness of vitamin D, a group of 220 experts have joined forces under the moniker of Vitamin D for All., Their Open Letter states: “Evidence to date suggests the possibility that the COVID-19 pandemic sustains itself in large part through infection of those with low vitamin D, and that deaths are concentrated largely in those with deficiency.” They recommend that adults increase vitamin D intakes from all sources to achieve serum 25(OH)D levels above 30 ng/ml.
Vitamin D for All suggests that adults whose 25(OH)D levels have not yet been tested consume 2,000–4,000 IU of vitamin D daily. People with an increased risk of deficiency due to overweight, ethnicity, advanced age, or comorbidities may need higher intakes. These recommendations are in line with established vitamin D guidelines issued by the Endocrine Society in 2011. Further clinical studies will help clarify the optimal 25(OH)D levels with respect to COVID-19.
Since vitamin D deficiency increases the risk of osteoporosis, frailty, diabetes, heart disease, other respiratory infections, and some cancers, supplementation to achieve adequate intakes has many potential health benefits.,,,,
Last but not least, Vitamin D for All acknowledges that numerous factors can predispose individuals to COVID-19 infections and their complications. They note, however, that “inadequate vitamin D may be the most easily and quickly modifiable risk factor with abundant evidence for a beneficial effect.” From a nutritional perspective, ensuring adequate vitamin D intake may be one of the best things we can do for our health, both during this pandemic and beyond.Click here to see References
 Gasmi A, et al. Interrelations between COVID-19 and other disorders. Clin Immunol. 2021 Mar;224:108651.
 Sanyaolu A, et al. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020 Jun 25;1-8.
 Bandeira L, et al. Clinical aspects of SARS-CoV-2 infection and vitamin D : COVID-19 and the endocrine system: special issue for reviews in endocrine and metabolic disorders. Rev Endocr Metab Disord. 2021 Sep 24;1-5.
 Pereira M, et al. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2020 Nov 4;1-9.
 Mercola J, et al. Evidence regarding vitamin D and risk of COVID-19 and its severity. Nutrients. 2020 Oct 31;12(11):3361.
 Lanham-New SA, et al. Vitamin D and SARS-CoV-2 virus/COVID-19 disease. BMJ Nutr Prev Health. 2020 May 13;3(1):106-10.
 Panagiotou G, et al. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol (Oxf). 2020 Oct;93(4):508-11.
 Rhein H. Vitamin D—let common sense prevail—on the balance of probabilities. Aging Clin Exp Res. 2021 Sep;33(9):2633.
 Sutherland JP, et al. Differences and determinants of vitamin D deficiency among UK biobank participants: a cross-ethnic and socioeconomic study. Clin Nutr. 2021 May;40(5):3436-47.
 Annweiler C, Souberbielle JC. Vitamin D supplementation and COVID-19: expert consensus and guidelines. Geriatr Psychol Neuropsychiatr Vieil. 2021 Oct 5. doi: 10.1684/pnv.2021.0955.
 National Library of Medicine. Search for “Vitamin D Covid”. October 10, 2021. Available from: https://pubmed.ncbi.nlm.nih.gov/?term=vitamin+d+covid
 Wacker M, Holick MF. Sunlight and vitamin D: a global perspective for health. Dermatoendocrinol. 2013 Jan 1;5(1):51-108.
 De Jongh RT, et al. Changes in vitamin D endocrinology during aging in adults. Mol Cell Endocrinol. 2017 Sep 15;453:144-50.
 Grant WB, et al. Seasonal variations of U.S. mortality rates: Roles of solar ultraviolet-B doses, vitamin D, gene expression, and infections. J Steroid Biochem Mol Biol. 2017 Oct;173:5-12.
 Webb AR, et al. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988 Aug;67(2):373-8.
 Mukherjee SB, et al. Seasonal UV exposure and vitamin D: association with the dynamics of COVID-19 transmission in Europe. FEBS Open Bio. 2021 Oct 5. doi: 10.1002/2211-5463.13309.
 Kaufman HW, et al. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One. 2020 Sep 17;15(9):e0239252.
 Petrelli F, et al. Therapeutic and prognostic role of vitamin D for COVID-19 infection: a systematic review and meta-analysis of 43 observational studies. J Steroid Biochem Mol Biol. 2021 Jul;211:105883.
 Jain A, et al. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep. 2020 Nov 19;10(1):20191.
 Akbar MR, et al. Low Serum 25-hydroxyvitamin D (Vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis. Front Nutr. 2021 Mar 29;8:660420.
 Yisak H, et al. Effects of vitamin D on COVID-19 infection and prognosis: a systematic review. Risk Manag Healthc Policy. 2021 Jan 7;14:31-8.
 Mariani J, et al. Association between vitamin D deficiency and COVID-19 incidence, complications, and mortality in 46 countries: an ecological study. Health Secur. May-Jun 2021;19(3):302-8.
 Pugach IZ, Pugach S. Strong correlation between prevalence of severe vitamin D deficiency and population mortality rate from COVID-19 in Europe. Wien Klin Wochenschr. 2021 Apr;133(7-8):403-5.
 Liu N, et al. Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis. Int J Infect Dis. 2021 Mar;104:58-64.
 Ghasemian R, et al. The role of vitamin D in the age of COVID-19: A systematic review and meta-analysis. Int J Clin Pract. 2021 Jul 29;e14675.
 Teshome A, et al. The impact of vitamin D level on COVID-19 infection: systematic review and meta-analysis. Front Public Health. 2021 Mar 5;9:624559.
 Szarpak L, et al. A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19. Cardiol J. 2021;28(5):647-54.
 Radujkovic A, et al. Vitamin D deficiency and outcome of COVID-19 patients. Nutrients. 2020 Sep 10;12(9):2757.
 Annweiler G, et al. Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 Patients: the GERIA-COVID quasi-experimental study. Nutrients. 2020 Nov 2;12(11):3377.
 Castillo ME, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020 Oct;203:105751.
 Shah K, et al. Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis. QJM. 2021 May 19;114(3):175-81.
 Oristrell J, et al. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. J Endocrinol Invest. 2021 Jul 17;1-13.
 Annweiler C, et al. Learning from previous methodological pitfalls to propose well-designed trials on vitamin D in COVID-19. J Steroid Biochem Mol Biol. 2021 Jul;211:105901.
 Smolders J, et al. Letter to the Editor: vitamin D deficiency in COVID-19: mixing up cause and consequence. Metabolism. 2021 Feb;115:154434.
 Chakhtoura M, Fuleihan GE. Reply to vitamin D deficiency in COVID-19: mixing up cause and consequence. Metabolism. 2021 Feb;115:154434.
 Trovas G, Tournis S. Vitamin D and COVID-19. Hormones (Athens). 2021 Mar;20(1):207-8.
 Gibson-Moore H. Vitamin D: what’s new a year on from the COVID-19 outbreak? Nutr Bull. 2021 Jun;46(2):195-205.
 Tarazona‐Santabalbina FJ, et al. Vitamin D supplementation for the prevention and treatment of COVID‐19: a position statement from the Spanish Society of Geriatrics and Gerontology. Revista Española de Geriatría y Gerontología. 2021;56(3):177-82.
 Vitamin D for All. Over 200 scientists & doctors call for increased vitamin D use to combat COVID-19 [Internet]. Vitamin D for All; 2021 [cited 2021 Oct 10]. Available from: https://vitamindforall.org/letter.html
 PR Newswire. 110-plus international experts release open letter: COVID-19 preys on those with vitamin D deficiency [Internet]. New York (NY): PR Newswire; 2021 [cited 2021 Oct 10]. Available from: https://www.prnewswire.com/news-releases/110-plus-international-experts-release-open-letter-covid-19-preys-on-those-with-vitamin-d-deficiency-301197338.html
 Holick MF, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30.
 Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017 Jun;18(2):153-65.
 Weaver CM, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016 Jan;27(1):367-76.
 Ensrud KE, et al. Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab. 2010 Dec;95(12):5266-73.
 Mirhosseini N, et al. Vitamin D supplementation, serum 25(OH)D concentrations and cardiovascular disease risk factors: a systematic review and meta-analysis. Front Cardiovasc Med. 2018 Jul 12;5:87.
 Umar M, et al. Role of vitamin D beyond the skeletal function: a review of the molecular and clinical studies. Int J Mol Sci. 2018 May 30;19(6).